Abstract
Current Neuropharmacology
Title: The Concept of “Neuroprotection” in Neurological Diseases
Volume: 2 Issue: 3
Author(s): Paolo Calabresi, Cinzia Costa, Diego Centonze, Antonio Pisani and Giorgio Bernardi
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Calabresi Paolo, Costa Cinzia, Centonze Diego, Pisani Antonio and Bernardi Giorgio, The Concept of “Neuroprotection” in Neurological Diseases, Current Neuropharmacology 2004; 2 (3) . https://dx.doi.org/10.2174/1570159043359701
DOI https://dx.doi.org/10.2174/1570159043359701 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Mitochondrial Toxins in Basal Ganglia Disorders: From Animal Models to Therapeutic Strategies
Current Neuropharmacology Functional Selectivity in Cannabinoid Signaling
Current Molecular Pharmacology Recent Advances in Cannabis sativa Research: Biosynthetic Studies and Its Potential in Biotechnology
Current Pharmaceutical Biotechnology Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function
Current Neuropharmacology Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART II
Current Neuropharmacology Editorial (Thematic Issue: Novel Perspectives for Parkinson’s Disease Therapy: Insights from the Latest Advances in Disease Pathophysiology, Diagnostic and Experimental Tools and Molecular Targets)
CNS & Neurological Disorders - Drug Targets Regulation of Dopamine Signaling in the Striatum by Phosphodiesterase Inhibitors: Novel Therapeutics to Treat Neurological and Psychiatric Disorders
Central Nervous System Agents in Medicinal Chemistry The Other Side of Opioid Receptor Signalling: Regulation by Protein-Protein Interaction
Current Drug Targets Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
Current Genomics Side Effects of Clozapine and Some Other Psychoactive Drugs
Current Drug Safety Multi- and Inter-Disciplinary Science in Personalized Delivery of Stem Cells for Tissue Repair
Current Stem Cell Research & Therapy Prediction and Targeting of Interaction Interfaces in G-protein Coupled Receptor Oligomers
Current Topics in Medicinal Chemistry Substance Abuse and Movement Disorders
Current Drug Abuse Reviews Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants
Current Pharmaceutical Design Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management
Current Neuropharmacology EDITORIAL [Hot Topic Recognition of Functional Roles of Free Radicals Guest Editor: István Bokkon]
Current Neuropharmacology Mathematical Models of Behavior of Individual Animals
Current Pharmaceutical Design A Comparison Between Quetiapine and Aripiprazole for Treatment of Schizophrenia: A Double Blind Contrast
Current Psychopharmacology A Systems Medicine Clinical Platform for Understanding and Managing Non- Communicable Diseases
Current Pharmaceutical Design Neural Stem Cells: From Neurobiology to Clinical Applications
Current Pharmaceutical Biotechnology